The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-Met co-expressing metastatic pancreatic adenocarcinoma (PDAC).
 
Anita Ahmed Turk
No Relationships to Disclose
 
Amikar Sehdev
Honoraria - Array BioPharma; Eisai; Incyte
Consulting or Advisory Role - Array BioPharma; Eisai; Incyte
Travel, Accommodations, Expenses - Array BioPharma; Eisai; Incyte
 
Safi Shahda
Employment - Lilly
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Ipsen
Research Funding - Apexian Pharmaceuticals (Inst); Incyte (Inst); Merck (Inst)
 
Bert O'Neil
Employment - Lilly
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
 
Paul R. Helft
No Relationships to Disclose
 
Aaron John Spittler
No Relationships to Disclose
 
Janet Flynn
No Relationships to Disclose
 
Patrick J. Loehrer
Research Funding - Lilly Foundation (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)